Antonio Leonardi

6.0k total citations · 1 hit paper
106 papers, 4.8k citations indexed

About

Antonio Leonardi is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Antonio Leonardi has authored 106 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 40 papers in Cancer Research and 39 papers in Immunology. Recurrent topics in Antonio Leonardi's work include NF-κB Signaling Pathways (32 papers), Immune Response and Inflammation (16 papers) and Cell death mechanisms and regulation (14 papers). Antonio Leonardi is often cited by papers focused on NF-κB Signaling Pathways (32 papers), Immune Response and Inflammation (16 papers) and Cell death mechanisms and regulation (14 papers). Antonio Leonardi collaborates with scholars based in Italy, United States and United Kingdom. Antonio Leonardi's co-authors include Francesco Pacifico, Ulrich Siebenlist, Guido Franzoso, Keith Brown, Louise Carlson, Elizabeth W. Shores, Ljiljana Poljak, Silvestro Formisano, Pasquale Vito and Brendan F. Boyce and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Antonio Leonardi

106 papers receiving 4.8k citations

Hit Papers

Requirement for NF-κB in osteoclast and B-cell development 1997 2026 2006 2016 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Requirement for NF-κB in osteoclast and B-cell development
    1997 840 citations Antonio Leonardi, Ulrich Siebenlist et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Leonardi Italy 36 2.6k 1.7k 1.7k 1.1k 306 106 4.8k
Jochen Heß Germany 36 3.2k 1.3× 1.2k 0.7× 1.4k 0.8× 1.4k 1.3× 454 1.5× 125 5.8k
Stéphane Plaisance Belgium 28 2.8k 1.1× 1.5k 0.9× 2.1k 1.2× 1.2k 1.1× 260 0.8× 48 5.9k
Erhard Hofer Austria 33 2.8k 1.1× 770 0.4× 1.7k 1.0× 928 0.9× 239 0.8× 72 5.3k
Robert Eferl Austria 33 3.8k 1.5× 1.3k 0.7× 1.4k 0.8× 2.0k 1.8× 529 1.7× 68 6.7k
David H. Lovett United States 50 2.5k 1.0× 1.8k 1.0× 1.0k 0.6× 995 0.9× 292 1.0× 126 6.6k
Ann Ranger United States 24 2.9k 1.1× 644 0.4× 2.9k 1.7× 1.0k 0.9× 406 1.3× 46 6.0k
Carl J. Kozlosky United States 18 3.1k 1.2× 1.2k 0.7× 2.1k 1.3× 2.0k 1.9× 515 1.7× 20 6.8k
Kenneth E. Lipson United States 47 3.3k 1.3× 737 0.4× 974 0.6× 1.2k 1.2× 293 1.0× 123 6.2k
Alexander Weidemann Germany 31 1.8k 0.7× 1.8k 1.0× 785 0.5× 478 0.4× 289 0.9× 46 4.2k
Anna‐Karin Olsson Sweden 28 2.7k 1.0× 848 0.5× 1.2k 0.7× 1.1k 1.1× 182 0.6× 65 4.8k

Countries citing papers authored by Antonio Leonardi

Since Specialization
Citations

This map shows the geographic impact of Antonio Leonardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Leonardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Leonardi more than expected).

Fields of papers citing papers by Antonio Leonardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Leonardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Leonardi. The network helps show where Antonio Leonardi may publish in the future.

Co-authorship network of co-authors of Antonio Leonardi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Leonardi. A scholar is included among the top collaborators of Antonio Leonardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Leonardi. Antonio Leonardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crescenzi, Elvira, Antonio Leonardi, & Francesco Pacifico. (2024). NF-κB in Thyroid Cancer: An Update. International Journal of Molecular Sciences. 25(21). 11464–11464. 5 indexed citations
2.
Crescenzi, Elvira, Antonio Leonardi, & Francesco Pacifico. (2023). Iron Metabolism in Cancer and Senescence: A Cellular Perspective. Biology. 12(7). 989–989. 14 indexed citations
3.
Sandomenico, Annamaria, Pier Paolo Olimpieri, Valeria Cicatiello, et al.. (2023). Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1. Biochemical and Biophysical Research Communications. 694. 149417–149417. 1 indexed citations
4.
Oliver, Angela, Monica Cantile, Pier Paolo Olimpieri, et al.. (2023). Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein. Pharmaceuticals. 16(8). 1130–1130. 1 indexed citations
5.
Pacifico, Francesco, Antonio Leonardi, & Elvira Crescenzi. (2023). Glutamine Metabolism in Cancer Stem Cells: A Complex Liaison in the Tumor Microenvironment. International Journal of Molecular Sciences. 24(3). 2337–2337. 25 indexed citations
6.
Pacifico, Francesco, Stefano Mellone, Maurizio D’Incalci, et al.. (2022). Trabectedin suppresses escape from therapy-induced senescence in tumor cells by interfering with glutamine metabolism. Biochemical Pharmacology. 202. 115159–115159. 14 indexed citations
7.
Leonardi, Antonio, et al.. (2021). New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates. International Journal of Molecular Sciences. 22(15). 7838–7838. 2 indexed citations
8.
Leonardi, Antonio, Angela Chambery, Rosita Russo, et al.. (2021). Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry. International Journal of Molecular Sciences. 22(6). 3166–3166. 6 indexed citations
9.
Strizzi, Luigi, et al.. (2019). Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro. Biochimie. 158. 246–256. 17 indexed citations
10.
Barra, Giusi, Alessio Lepore, Miriam Gagliardi, et al.. (2018). Sphingosine Kinases promote IL-17 expression in human T lymphocytes. Scientific Reports. 8(1). 13233–13233. 18 indexed citations
11.
Manzo, Emiliano, Adele Cutignano, Carmela Gallo, et al.. (2017). A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response. Scientific Reports. 7(1). 6286–6286. 49 indexed citations
12.
Calvanese, Luisa, Annamaria Sandomenico, Andrea Caporale, et al.. (2017). Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy. Bioorganic & Medicinal Chemistry. 25(24). 6589–6596. 7 indexed citations
13.
Paolin, Adolfo, Diletta Trojan, Antonio Leonardi, et al.. (2016). Cytokine expression and ultrastructural alterations in fresh-frozen, freeze-dried and γ-irradiated human amniotic membranes. Cell and Tissue Banking. 17(3). 399–406. 48 indexed citations
14.
Napolitano, Gennaro, et al.. (2015). COMMD7 as a novel NEMO interacting protein involved in the termination of NF‐κB signaling. Journal of Cellular Physiology. 231(1). 152–161. 20 indexed citations
15.
Ziviello, Francesca, Stefano Conte, Giovanni Cimmino, et al.. (2014). The adipokine apelin-13 induces expression of prothrombotic tissue factor. Thrombosis and Haemostasis. 113(2). 363–372. 20 indexed citations
16.
Claudio, Estefanı́a, Søren Ulrik Sønder, Sun Saret, et al.. (2009). The Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation. The Journal of Immunology. 182(3). 1617–1630. 117 indexed citations
17.
Lavorgna, Alfonso, Rosaria De Filippi, Silvestro Formisano, & Antonio Leonardi. (2009). TNF receptor-associated factor 1 is a positive regulator of the NF-κB alternative pathway. Molecular Immunology. 46(16). 3278–3282. 23 indexed citations
18.
Pacifico, Francesco, Gennaro Chiappetta, Elvira Crescenzi, et al.. (2007). RbAp48 is a Target of Nuclear Factor-κB Activity in Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 92(4). 1458–1466. 35 indexed citations
19.
Mauro, Claudio, Pasquale Vito, Stefano Mellone, et al.. (2003). Role of the adaptor protein CIKS in the activation of the IKK complex. Biochemical and Biophysical Research Communications. 309(1). 84–90. 21 indexed citations
20.
Leonardi, Antonio, Maresa Altomonte, Michele Maio, et al.. (1997). BIPHASIC CONTROL OF NF-κB ACTIVATION INDUCED BY THE TRIGGERING OF HLA-DR ANTIGENS EXPRESSED ON B CELLS. Cytokine. 9(5). 295–299. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Heß Breakdown of academic impact, for papers by Stéphane Plaisance Breakdown of academic impact, for papers by Erhard Hofer Breakdown of academic impact, for papers by Robert Eferl Breakdown of academic impact, for papers by David H. Lovett Breakdown of academic impact, for papers by Ann Ranger Breakdown of academic impact, for papers by Carl J. Kozlosky Breakdown of academic impact, for papers by Kenneth E. Lipson Breakdown of academic impact, for papers by Alexander Weidemann Breakdown of academic impact, for papers by Anna‐Karin Olsson
Rankless by CCL
2026